Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
2,032 rows where in_cev_map = 0 and surface_class = "B_cargo" sorted by evidence_priority descending
This data as json, CSV (advanced)
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P00439 | PAH | Phenylalanine-4-hydroxylase | Tier 1 | 0.618 | 1 | B_cargo | 20 | 88.69 | 0 | 0 | 1 | 11 | 39435559, 35394406, 35081018, 34973551, 33386219, 32587339, 31349094, 26043089, 24749544, 23583275, 16914451 | 0 | phenylketonuria | 0.892702971437507 | ||
| P40337 | VHL | von Hippel-Lindau disease tumor suppressor | Tier 1 | 0.616 | 1 | B_cargo | 100 | 84.44 | 0 | 0 | 1 | 5 | 39437434, 36250201, 34549489, 23142634, 17290195 | 0 | von Hippel-Lindau disease | 0.8883247767048489 | ||
| Q13315 | ATM | Serine-protein kinase ATM | Tier 1 | 0.613 | 1 | B_cargo | 14 | 1 | 0 | 1 | 9 | 41867498, 39253616, 37656667, 34733968, 28838608, 28706912, 26176230, 17386435, 15181173 | 0 | ataxia telangiectasia | 0.8759719859489208 | |||
| P22304 | IDS | Iduronate 2-sulfatase | Tier 1.5 | 0.613 | 1 | B_cargo | 2 | 93.06 | 0 | 0 | 1 | 9 | 41791433, 41521476, 41396069, 40394224, 37948569, 31273548, 30529550, 28420169, 20842131 | 0 | mucopolysaccharidosis type 2 | 0.8781523206667287 | ||
| O00255 | MEN1 | Menin | Tier 1 | 0.61 | 1 | B_cargo | 61 | 84.44 | 0 | 0 | 0 | 0 | 0 | multiple endocrine neoplasia type 1 | 0.8653255032429027 | |||
| P35670 | ATP7B | Copper-transporting ATPase 2 | Tier 1 | 0.61 | 1 | B_cargo | 13 | 71.69 | 1 | 0 | 1 | 1 | 39737993 | 0 | Wilson disease | 0.8657500553466239 | ||
| P35557 | GCK | Hexokinase-4 | Tier 1 | 0.609 | 1 | B_cargo | 35 | 93.69 | 0 | 0 | 0 | 0 | 0 | MODY | 0.8633086470947097 | |||
| O43602 | DCX | Neuronal migration protein doublecortin | Tier 1 | 0.609 | 1 | B_cargo | 18 | 66.5 | 1 | 0 | 0 | 0 | 0 | lissencephaly type 1 due to doublecortin gene mutation | 0.864453842605602 | |||
| Q8NCM8 | DYNC2H1 | Cytoplasmic dynein 2 heavy chain 1 | Tier 1.5 | 0.608 | 1 | B_cargo | 4 | 83.44 | 1 | 0 | 0 | 0 | 0 | asphyxiating thoracic dystrophy 3 | 0.8610362911667925 | |||
| P21549 | AGXT | Alanine--glyoxylate aminotransferase | Tier 1 | 0.607 | 1 | B_cargo | 17 | 98.31 | 0 | 0 | 0 | 0 | 0 | primary hyperoxaluria type 1 | 0.8572717660798254 | |||
| O14746 | TERT | Telomerase reverse transcriptase | Tier 1 | 0.607 | 1 | B_cargo | 23 | 80.19 | 1 | 0 | 1 | 13 | 41104418, 40347637, 40062394, 39513874, 39441744, 37427434, 36005058, 35658460, 33476148, 28004350, 24176970, 22013508 | 0 | dyskeratosis congenita, autosomal dominant 2 | 0.8577919827748599 | ||
| P04629 | NTRK1 | High affinity nerve growth factor receptor | Tier 1 | 0.607 | 1 | B_cargo | 65 | 78.25 | 0 | 0 | 1 | 1 | 38604287 | 0 | hereditary sensory and autonomic neuropathy type 4 | 0.8579248191890114 | ||
| Q9BZS1 | FOXP3 | Forkhead box protein P3 | Tier 1 | 0.606 | 1 | B_cargo | 2 | 56.72 | 0 | 0 | 1 | 8 | 40448637, 34457999, 32892748, 26999456, 24460675, 22323540, 18698484, 18319343 | 0 | immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | 0.8516802661294931 | ||
| P19544 | WT1 | Wilms tumor protein | Tier 1 | 0.606 | 1 | B_cargo | 28 | 50.78 | 0 | 0 | 1 | 3 | 27417971, 19123921, 11329270 | 0 | Denys-Drash syndrome | 0.8525486743466777 | ||
| P37231 | PPARG | Peroxisome proliferator-activated receptor gamma | Tier 1 | 0.605 | 1 | B_cargo | 100 | 76.12 | 0 | 0 | 1 | 3 | 37203464, 33671292, 28206680 | 0 | type 2 diabetes mellitus | 0.8486094742593474 | ||
| Q9Y6K1 | DNMT3A | DNA (cytosine-5)-methyltransferase 3A | Tier 1 | 0.605 | 1 | B_cargo | 43 | 72.94 | 1 | 0 | 1 | 3 | 39079576, 31733056, 23179556 | 0 | acute myeloid leukemia | 0.8505245588442946 | ||
| Q3T906 | GNPTAB | N-acetylglucosamine-1-phosphotransferase subunits alpha/beta | Tier 1 | 0.605 | 1 | B_cargo | 5 | 71.62 | 1 | 0 | 0 | 0 | 0 | mucolipidosis type III, alpha/beta | 0.8490445308315259 | |||
| P23760 | PAX3 | Paired box protein Pax-3 | Tier 1 | 0.605 | 1 | B_cargo | 1 | 63.94 | 0 | 0 | 0 | 0 | 0 | Waardenburg syndrome type 1 | 0.8500072027894306 | |||
| P54132 | BLM | RecQ-like DNA helicase BLM | Tier 1 | 0.605 | 1 | B_cargo | 15 | 60.53 | 0 | 0 | 1 | 9 | 40700985, 38959435, 34973563, 33571410, 33050386, 31563064, 30343567, 27332117, 19146404 | 0 | Bloom syndrome | 0.8491084997646711 | ||
| O76039 | CDKL5 | Cyclin-dependent kinase-like 5 | Tier 1.5 | 0.605 | 1 | B_cargo | 3 | 53.12 | 0 | 0 | 0 | 0 | 0 | developmental and epileptic encephalopathy, 2 | 0.8510325653635987 | |||
| Q9UIF7 | MUTYH | Adenine DNA glycosylase | Tier 1.5 | 0.605 | 1 | B_cargo | 3 | 78.94 | 0 | 0 | 0 | 0 | 0 | familial adenomatous polyposis 2 | 0.8483469680730393 | |||
| Q96RY7 | IFT140 | Intraflagellar transport protein 140 homolog | Tier 1 | 0.604 | 1 | B_cargo | 4 | 80.12 | 1 | 0 | 0 | 0 | 0 | short-rib thoracic dysplasia 9 with or without polydactyly | 0.8464676938353167 | |||
| P54098 | POLG | DNA polymerase subunit gamma-1 | Tier 1 | 0.604 | 1 | B_cargo | 36 | 78.94 | 1 | 0 | 0 | 0 | 0 | mitochondrial DNA depletion syndrome 4a | 0.8474167021250057 | |||
| P40692 | MLH1 | DNA mismatch repair protein Mlh1 | Tier 1 | 0.604 | 1 | B_cargo | 7 | 77.31 | 0 | 0 | 0 | 0 | 0 | Lynch syndrome | 0.8472183133029993 | |||
| O15360 | FANCA | Fanconi anemia group A protein | Tier 1 | 0.604 | 1 | B_cargo | 6 | 74.88 | 1 | 0 | 0 | 0 | 0 | Fanconi anemia complementation group A | 0.8469248580955555 | |||
| Q92574 | TSC1 | Hamartin | Tier 1 | 0.604 | 1 | B_cargo | 5 | 62.06 | 1 | 0 | 1 | 1 | 18974095 | 0 | tuberous sclerosis | 0.8476796313298992 | ||
| Q2NKJ3 | CTC1 | CST complex subunit CTC1 | Tier 1 | 0.603 | 1 | B_cargo | 7 | 77.5 | 1 | 0 | 0 | 0 | 0 | Coats plus syndrome | 0.8438631461095314 | |||
| Q92793 | CREBBP | CREB-binding protein | Tier 1 | 0.603 | 1 | B_cargo | 100 | 52.53 | 0 | 0 | 1 | 1 | 39429683 | 0 | Rubinstein-Taybi syndrome due to CREBBP mutations | 0.8442311239876018 | ||
| Q2M1P5 | KIF7 | Kinesin-like protein KIF7 | Tier 1.5 | 0.603 | 1 | B_cargo | 5 | 67.19 | 1 | 0 | 0 | 0 | 0 | acrocallosal syndrome | 0.8424257475739304 | |||
| O60931 | CTNS | Cystinosin | Tier 1.5 | 0.603 | 1 | B_cargo | 6 | 89.44 | 1 | 0 | 0 | 0 | 0 | nephropathic cystinosis | 0.841818398377195 | |||
| P58012 | FOXL2 | Forkhead box protein L2 | Tier 1.5 | 0.603 | 1 | B_cargo | 2 | 60.12 | 0 | 0 | 1 | 1 | 37933840 | 0 | blepharophimosis, ptosis, and epicanthus inversus syndrome | 0.841709236718747 | ||
| Q12879 | GRIN2A | Glutamate receptor ionotropic, NMDA 2A | Tier 1 | 0.602 | 1 | B_cargo | 37 | 60.84 | 1 | 0 | 0 | 0 | 0 | Landau-Kleffner syndrome | 0.8407159711916629 | |||
| P38398 | BRCA1 | Breast cancer type 1 susceptibility protein | Tier 1 | 0.602 | 1 | B_cargo | 33 | 41.59 | 1 | 0 | 1 | 13 | 40251554, 37288783, 36858016, 32945515, 32245065, 29737162, 28841982, 26784987, 24734899, 23836560, 21800393, 16825284 | 0 | breast cancer | 0.839035109761358 | ||
| P20823 | HNF1A | Hepatocyte nuclear factor 1-alpha | Tier 1.5 | 0.602 | 1 | B_cargo | 6 | 56.97 | 0 | 0 | 1 | 4 | 15781225, 15629461 | 0 | MODY | 0.8405262466243777 | ||
| P38935 | IGHMBP2 | DNA-binding protein SMUBP-2 | Tier 1.5 | 0.602 | 1 | B_cargo | 4 | 77.38 | 0 | 0 | 0 | 0 | 0 | autosomal recessive distal spinal muscular atrophy 1 | 0.8396147647161344 | |||
| Q9HBG6 | IFT122 | Intraflagellar transport protein 122 homolog | Tier 1.5 | 0.602 | 1 | B_cargo | 5 | 82.88 | 1 | 0 | 0 | 0 | 0 | cranioectodermal dysplasia | 0.8402296001002503 | |||
| O43435 | TBX1 | T-box transcription factor TBX1 | Tier 1.5 | 0.602 | 1 | B_cargo | 1 | 68.19 | 0 | 0 | 1 | 1 | 24797903 | 0 | 22q11.2 deletion syndrome | 0.8406035626999856 | ||
| P82279 | CRB1 | Protein crumbs homolog 1 | Tier 1.5 | 0.602 | 1 | B_cargo | 1 | 75.06 | 0 | 0 | 0 | 0 | 0 | Leber congenital amaurosis 8 | 0.8398871782775204 | |||
| P20807 | CAPN3 | Calpain-3 | Tier 1 | 0.601 | 1 | B_cargo | 5 | 78.25 | 0 | 0 | 0 | 0 | 0 | autosomal recessive limb-girdle muscular dystrophy type 2A | 0.8360959201056175 | |||
| O60260 | PRKN | E3 ubiquitin-protein ligase parkin | Tier 1 | 0.601 | 1 | B_cargo | 21 | 78.06 | 0 | 0 | 0 | 0 | 0 | Young adult-onset Parkinsonism | 0.8361755700457273 | |||
| Q8N159 | NAGS | N-acetylglutamate synthase, mitochondrial | Tier 1.5 | 0.601 | 1 | B_cargo | 1 | 79.75 | 0 | 0 | 0 | 0 | 0 | hyperammonemia due to N-acetylglutamate synthase deficiency | 0.8382373711482316 | |||
| Q02127 | DHODH | Dihydroorotate dehydrogenase (quinone), mitochondrial | Tier 1 | 0.6 | 1 | B_cargo | 100 | 96.12 | 0 | 0 | 1 | 1 | 29626096 | 0 | postaxial acrofacial dysostosis | 0.8330628404263816 | ||
| Q7Z2E3 | APTX | Aprataxin | Tier 1 | 0.6 | 1 | B_cargo | 11 | 80.75 | 0 | 0 | 0 | 0 | 0 | ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | 0.832110422501825 | |||
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | Tier 1 | 0.6 | 1 | B_cargo | 44 | 77.5 | 1 | 0 | 1 | 4 | 38467937, 37586882, 37422510, 36774388 | 0 | Hereditary late-onset Parkinson disease | 0.8349742982582067 | ||
| Q13402 | MYO7A | Unconventional myosin-VIIa | Tier 1 | 0.6 | 1 | B_cargo | 1 | 77.25 | 0 | 0 | 0 | 0 | 0 | Usher syndrome type 1B | 0.8326791560829035 | |||
| Q15910 | EZH2 | Histone-lysine N-methyltransferase EZH2 | Tier 1 | 0.6 | 1 | B_cargo | 38 | 76.25 | 1 | 0 | 1 | 8 | 41574287, 41223251, 40931580, 39853766, 36626902, 32884286, 30795863, 27719642 | 0 | Weaver syndrome | 0.8324078192564933 | ||
| P49715 | CEBPA | CCAAT/enhancer-binding protein alpha | Tier 1 | 0.6 | 1 | B_cargo | 2 | 61.69 | 0 | 0 | 1 | 7 | 38965606, 30909853, 31546149, 30795863, 28639199, 26983359 | 0 | acute myeloid leukemia | 0.8336701187896877 | ||
| Q2TBA0 | KLHL40 | Kelch-like protein 40 | Tier 1.5 | 0.6 | 1 | B_cargo | 1 | 89.44 | 0 | 0 | 0 | 0 | 0 | nemaline myopathy 8 | 0.8348979900805442 | |||
| Q9BXW9 | FANCD2 | Fanconi anemia group D2 protein | Tier 1.5 | 0.6 | 1 | B_cargo | 13 | 76.75 | 1 | 0 | 0 | 0 | 0 | Fanconi anemia complementation group D2 | 0.8319139646572291 | |||
| Q9BY41 | HDAC8 | Histone deacetylase 8 | Tier 1 | 0.599 | 1 | B_cargo | 53 | 95.31 | 0 | 0 | 0 | 0 | 0 | Cornelia de Lange syndrome | 0.8312421317616957 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;